NCT01109537View on ClinicalTrials.gov

Altered Brain GABA and Glutamate in Restless Legs Syndrome

CompletedOBSERVATIONAL

Enrollment

75

Participants

Timeline

Start Date

April 30, 2010

Primary Completion Date

May 31, 2014

Study Completion Date

May 31, 2014

Conditions

Restless Legs Syndrome

Trial Locations (1)

02135

Sleep HealthCenters, Brighton

Sponsors

Collaborators (1)

GlaxoSmithKline

All Listed Sponsors

collaborator

GlaxoSmithKline

INDUSTRY

lead

Brigham and Women's Hospital

OTHER

NCT01109537 - Altered Brain GABA and Glutamate in Restless Legs Syndrome | Biotech Hunter | Biotech Hunter